EDITORIAL from NEJM Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease .

The Food and Drug Administration approved the first direct oral anticoagulant nearly a decade ago.
Since then, antithrombotic therapy has evolved swiftly, with research systematically addressing the use of these agents for the treatment of com-mon medical conditions, such as atrial fibrilla-tion. Of particular concern in recent years has been the question of how to manage atrial fibril-lation and coronary artery disease when they occur together in the same patient.

למאמר המלא

Antithrombotic Therapy in Atrial Fibrillation and Coronary

השארת תגובה

חייבים להתחבר כדי להגיב.

גלילה לראש העמוד
דילוג לתוכן
%d בלוגרים אהבו את זה: